Clinical Trial Update: Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating inhaled amiloride and inhaled tobramycin for eradication of Burkholderia dolosa in cystic fibrosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Amiloride Solution for Inhalation (amiloride)
• Tobramycin Solution for Inhalation (tobramycin)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED